Atkinson Edward Morrow III
Vertex Pharmaceuticals Inc · EVP
Atkinson Edward Morrow III is listed in filings as EVP at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Feb 26, 2026, including sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX). The current snapshot covers public activity from Feb 14, 2025 to Feb 26, 2026. Reported amounts are shown as $324.9K to $387.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $387k817 shares | SellFeb 18, 2026 | $473.68 | $481.00 | |
| $994k2k shares | SellFeb 17, 2026 | $489.46 | $481.00 | |
| $806k1.8k shares | SellFeb 11, 2026 | $460.43 | $481.00 | |
| $1M2.5k shares | SellNov 17, 2025 | $434.58 | $481.00 | |
| $1M2.7k shares | SellFeb 27, 2025 | $475.34 | $481.00 | |
| $850k1.8k shares | SellFeb 25, 2025 | $480.95 | $481.00 |